ASP Isotopes Inc.（ASPI）股票分析ASPIASP Isotopes Inc.

ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. Its proprietary technologies, the Aerodynamic Separation Process and Quantum Enrichment technology, are designed to enable the production of isotopes used in several industries. Its initial focus is on the production and commercialization of enriched Carbon-14 (C-14), Silicon-28 (Si-28) and Ytterbium-176 (Yb-176). It is also a provider of liquid helium with operations at the Virginia Gas Project in South Africa. Its nuclear fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its specialist isotopes and related services segment is focused on research and development of technologies and methods used to separate isotopes for highly specialized target end markets. It operates in the Healthcare sector (MISCELLANEOUS CHEMICAL PRODUCTS industry).

ASPI is not a good buy right now due to its current price of 1.945, a very low RSI of 25.467 indicating oversold conditions, and a staggering year-to-date change of -65.45%. The significant losses in net income, with a net income of -33,585,000 in Q2 2026, raise concerns about the company's financial health. The forward P/E ratio of 54.35 suggests that the stock is overvalued relative to its earnings potential, and the gross margin of 28.89% is declining, indicating potential operational challenges.